Latent Labs, founded in 2023, is pioneering the biotechnology landscape by making biology programmable, aiming to revolutionize health and sustainability. Their slogan aptly captures their mission: "Frontier models for all molecules of life." This innovative company positions itself at the cutting edge of AI and molecular biology, designing foundational models that empower the creation of new antibodies, the optimization of enzymes, and advancements in genetic engineering.
Recently, Latent Labs secured a $50.00M Series A investment as of 01 February 2025, underscoring strong investor confidence. This fundraising round saw participation from a diverse group of investors, including Kindred Capital, Pillar, 8VC, Sofinnova Partners, Flying Fish Partners, Isomer Capital, Radical Ventures, Tanis Ventures, and Aidan Gomez. These partnerships highlight the potential of Latent Labs to become a pivotal player in the biotech industry.
